Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02652247 · ClinicalTrials.gov registry record · NA
Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients
A NA study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT02652247: Clinical Trial NA study, sponsored by Vanderbilt University Medical Center.
NCT02652247 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02652247, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
To determine if the analysis of exhaled breath condensate correlates with the development \& resolution of pneumonia.
Primary Outcome
To determine the association between the microbial community in both EBCF specimens and bronchoalveolar lavage fluid (BALF) samples in critically ill and injured, mechanically ventilated patients suspected of VAP.
Interventions
- PROCEDURE molecular analysis of exhaled breath condensate
- PROCEDURE molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate
- PROCEDURE molecular analysis of bronchoalveolar lavage (BAL) aspirate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2016-01 |
| Est. Completion | 2022-06 |
| Phase | NA |
Why NCT02652247 stopped before completion
NCT02652247 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which molecular analysis of exhaled breath condensate is the first listed.
NCT02652247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02652247 about?
NCT02652247 is a clinical study titled "Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients". To determine if the analysis of exhaled breath condensate correlates with the development \& resolution of pneumonia.
What is the current status of trial NCT02652247?
This trial is currently terminated. It is a NA study. The enrollment target is 110 participants. The study started on 2016-01. Estimated completion is 2022-06.
What interventions are being tested in trial NCT02652247?
The interventions under investigation include: molecular analysis of exhaled breath condensate (PROCEDURE), molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate (PROCEDURE), molecular analysis of bronchoalveolar lavage (BAL) aspirate (PROCEDURE).
Who is sponsoring clinical trial NCT02652247?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02652247's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia